Citigroup Inc Regencell Bioscience Holdings LTD Transaction History

Citigroup Inc

  • $169 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$20.67 - $45.78 $46,300 - $102,547
-2,240 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$21.4 - $40.0 $47,936 - $89,600
2,240 New
2,240 $48,000

Others Institutions Holding RGC

# of Institutions
3
Shares Held
18.1K
Call Options Held
0
Put Options Held
0
View Full List

About Regencell Bioscience Holdings Ltd

RGC Quotes by TradingView
  • Ticker RGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,012,900
  • Market Cap $79.4M
  • Description
  • Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...
More about RGC
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email